|
|
|
Volumn 38, Issue 5, 2013, Pages
|
|
Pharmaceutical approval update
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA1A INTERFERON;
CAPECITABINE;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN;
FINGOLIMOD;
FUMADERM;
FUMARIC ACID DIMETHYL ESTER;
GLATIRAMER;
LAPATINIB;
NATALIZUMAB;
OSPEMIFENE;
TERIFLUNOMIDE;
TRASTUZUMAB EMTANSINE;
ADULT RESPIRATORY DISTRESS SYNDROME;
ALLERGIC REACTION;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
APOPTOSIS;
BREAST CANCER;
BREAST METASTASIS;
CARDIOTOXICITY;
CARDIOVASCULAR DISEASE;
CELL CYCLE ARREST;
CELL DAMAGE;
CEREBROVASCULAR ACCIDENT;
DELAYED DRUG RELEASE;
DRUG APPROVAL;
DRUG MECHANISM;
DRUG WITHDRAWAL;
DYSPAREUNIA;
ENDOMETRIUM CANCER;
ENDOMETRIUM HYPERPLASIA;
ESTROGEN THERAPY;
FETUS DEATH;
FLUSHING;
GENITAL BLEEDING;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE FUNCTION;
HUMAN;
HYPOPLASIA;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INFLAMMATION;
INTERSTITIAL LUNG DISEASE;
ISCHEMIC HEART DISEASE;
LIVER DISEASE;
LIVER TOXICITY;
LUNG TOXICITY;
LYMPHOCYTOPENIA;
MULTIPLE SCLEROSIS;
NEUROTOXICITY;
NOTE;
OXIDATIVE STRESS;
PNEUMONIA;
POLYP;
PROTEIN EXPRESSION;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECOMMENDED DRUG DOSE;
RISK FACTOR;
SIDE EFFECT;
SKELETON MALFORMATION;
THROMBOCYTOPENIA;
VASCULAR DISEASE;
VENOUS THROMBOEMBOLISM;
|
|
EID: 84878029258
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
